{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-24-000023","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2024-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.480693+00:00","generated_at":"2026-06-05T15:32:32.118211+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Hims & Hers FY2023 revenue $872M (+65% YoY); Q4 net income $1.2M; guides FY2024 rev $1.17-1.20B","bullets":["FY2023 revenue $872.0M, up 65% YoY; net loss improved to $(23.5)M from $(65.7)M.","Q4 2023 revenue $246.6M (+47% YoY); first net income quarter of $1.2M vs $(10.9)M loss.","Adjusted EBITDA Q4 $20.6M vs $3.9M; FY2023 Adj. EBITDA $49.5M vs $(15.8M) loss.","Subscribers reached 1.54M, up 48% YoY; monthly online revenue per subscriber $53.","Guides FY2024 revenue $1.17B-$1.20B; Adj. EBITDA $100M-$120M, beating 2025 target early."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-24-000023","json":"https://secwatch.observer/filing/0001773751-24-000023.json","markdown":"https://secwatch.observer/filing/0001773751-24-000023.md","text":"https://secwatch.observer/filing/0001773751-24-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/hims-20240226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T15:32:32.118211+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c6b3a39ff568427cd5343f8b368b79627f3058d","claim":"Hims & Hers Health, Inc. reported the year ended December 31, 2023 results: revenue $872.0 million, net income $(23.5) million. Guidance initiated.","evidence_excerpt":"Revenue was $872.0 million for the year ended December 31, 2023 compared to $526.9 million for the year ended December 31, 2022, an increase of 65% year-over-year. • Gross margin was 82% for the year ended December 31, 2023 compared to 78% for the year ended December 31, 2022. • Net loss was $(23.5) million for the year ended December 31, 2023 compared to $(65.7) million for the year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Revenue","value":"$872.0 million"},{"label":"Net income","value":"$(23.5) million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"46c44ab19e3097ab73635717116befa3ec26b187","claim":"Hims & Hers Health, Inc. reported the fourth quarter of 2023 results: revenue $246.6 million, net income $1.2 million. Guidance initiated.","evidence_excerpt":"Revenue was $246.6 million for the fourth quarter of 2023 compared to $167.2 million for the fourth quarter of 2022, an increase of 47% year-over-year. • Gross margin was 83% for the fourth quarter of 2023 compared to 79% for the fourth quarter of 2022. • Net income was $1.2 million for the fourth quarter of 2023 compared to a net loss of $(10.9) million for the fourth quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1773751/000177375124000023/0001773751-24-000023-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter of 2023"},{"label":"Revenue","value":"$246.6 million"},{"label":"Net income","value":"$1.2 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}